Miura, Nami <br/><br/>
Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4.  [electronic resource] 

 -  Oncotarget  May 2016 
 - 33165-78 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.8890  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>A549 Cells<br/>Actinin--metabolism<br/>Adenocarcinoma--drug therapy<br/>Adenocarcinoma of Lung<br/>Aged<br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--metabolism<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Movement--drug effects<br/>Chemotherapy, Adjuvant<br/>Clinical Trials as Topic<br/>Databases, Factual<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Mice, SCID<br/>Middle Aged<br/>Neoplasm Invasiveness<br/>Neoplasm Staging<br/>Pneumonectomy<br/>Proportional Hazards Models<br/>RNA Interference<br/>Time Factors<br/>Transfection<br/>Treatment Outcome<br/>Xenograft Model Antitumor Assays